RepliCel Life Sciences Inc (OTCQB:REPCF)

0.47
Delayed Data
As of Mar 27
 +0.0753 / +19.08%
Today’s Change
0.26
Today|||52-Week Range
0.74
+45.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-2.3M-3.8M-3.4M-27.7K
 
 
 
 
 
Depreciation6.7K7.7K6.1K5.9K
 
 
 
 
 
Total Other Cash Flow1.1M977.1K265.2K519.5K
 
 
 
 
 
Funds From Operations-1.2M-2.8M-3.1M497.7K
 
 
 
 
 
Funds From/For Other Operating Expenses-368.3K380.6K-134.3K17.7K
 
 
 
 
 
Net Cash Flow - Operating Activities-816.4K-3.1M-3.0M480.0K
 
 
 
 
 
 
InvestingCapital Expenditures-19.9K-13.1K-9.1K-7.6K
 
 
 
 
 
Other Investing - Sources1.1M0.000.000.00
 
 
Net Cash Flow Investing1.1M-13.1K-9.1K-7.6K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale400.7K2.5M2.8M1.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing51.9K0.0035.7K45.3K
 
 
 
 
Net Cash Flow - Financing348.8K2.5M2.8M1.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash589.9K-653.3K-180.9K1.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account